Vasoocclusion leads to pain, chronic organ damage, and a decreased life expectancy in patients with sickle cell disease. Therapeutic options for sickle cell disease have usually been evaluated according to their capacity for reducing the frequency of vasoocclusive crises requiring clinical attention
A new look at neuropathology in sickle cell disease
โ Scribed by George J. Dover
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 79 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Antiphospholipid antibody formation can be Induced In mice by phospholipid In a hexagonal II phase but not by phospholipid in a bllayer phase. Since sickle red cell membranes have increased hexagonal I1 phase content, we have measured serum antiphospholipid antibody levels in 25 patients with sickle
Sickle red blood cell (SRBC)-endothelial adhesion plays a central role in sickle cell disease (SCD)-related vaso-occlusion. As unusually large von Willebrand factor (ULVWF) multimers mediate SRBC-endothelial adhesion, we investigated the activity of ADAMTS13, the metalloprotease responsible for clea